Cargando…
Block of Voltage-Gated Sodium Channels by Atomoxetine in a State- and Use-dependent Manner
Atomoxetine, a neuroactive drug, is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD). It is primarily known as a high affinity blocker of the noradrenaline transporter, whereby its application leads to an increased level of the corresponding neurotransmitter in different...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959846/ https://www.ncbi.nlm.nih.gov/pubmed/33732157 http://dx.doi.org/10.3389/fphar.2021.622489 |